T. Rowe Price Investment Management, Inc. Embecta Corp. Transaction History

T. Rowe Price Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $68.4 Million - $101 Million	-4,558,309 Reduced 90.06%	502,918 $7.57 Million
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $12 Million - $17.1 Million	-555,774 Reduced 9.89%	5,061,227 $109 Million
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $36.5 Million - $51.8 Million	1,582,016 Added 39.21%	5,617,001 $158 Million
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $19.3 Million - $27.1 Million	762,630 Added 23.31%	4,034,985 $102 Million
Q3 2022 Nov 14, 2022	BUY	$24.0 - $33.42 $78.5 Million - $109 Million	3,272,355 New	3,272,355 $94.2 Million

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.